– Consult a doctor before use if you have a medical condition, take medication, or are prone to priapism.
– Avoid using with nitrates, alpha-blockers, or other PDE5 inhibitors.
In this study, the mean IELT was lower than in other studies as most of our patients did not seek medical advice except if PE is severe and responsible for major negative personal and partnership consequences. In this study headache and flushing, as adverse effects of treatment, were more pronounced in group 3 with a statistically significant variation (P = 0.036, < 0.001). For clinical implications, we recommend to start with a single drug and shift to the combination therapy in patients who are not improved by monotherapy. This work had some limitations including short follow-up period, after therapy was stopped, sildenafil and dapoxetine individuals were not observed, and it was not placebo controlled. Both tadalafil and dapoxetine are effective in the treatment of PE as a single drug, but the combination of both gives more pronounced improvement, however with a slightly increased incidence of side effects.
The combination of both drugs in cases who are not satisfied with monotherapy can be considered. No potential conflict of interest was reported by the author(s). Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction—DAP-SPEED study. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Desk reference to the diagnostic criteria from DSM-5-TR. – Do not take more than the recommended dose. Other combination medications for ED and PE, such as Cialis + Priligy. Menarini, Singapore; Berlin Chemie, Bosnia & Herzegowina; Berlin-Chemie, Croatia (Hrvatska); Berlin-Chemie, Lithuania; Berlin-Chemie, Latvia; Berlin-Chemie, Romania; Berlin-Chemie/ Menarini, Poland; Janssen, Lebanon; Menarini, Slovakia; UFSA, Turkey; Zuellig, Philippines PriligyA Menarini Australia, Australia; A. Menarini, Hong Kong; A. Menarini, Ireland; A. Menarini, South Korea; A. Menarini, Portugal; A. Menarini, Thailand; A.
| Medication Class | Interaction Type | Potential Effect | Notes |
|---|---|---|---|
| CYP3A4 inhibitors | Increased drug levels | Higher risk of side effects | e.g., ketoconazole, ritonavir |
| Nitrates | Severe hypotension | Dangerous blood pressure drop | Contraindicated |
| Alcohol | Increased sedation | Dizziness, hypotension | Use with caution |
| Antihypertensive medications | Additive blood pressure lowering | Risk of hypotension | Monitor blood pressure |
Menarini Farmaceutica Internazionale, United Kingdom; A.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Priligy Generic Dapoxetine | 60mg | 60 + 8 Pills | 183.06€ 174.34€ | |
| Priligy Generic Dapoxetine | 60mg | 180 + 10 Pills | 494.76€ 471.20€ | |
| Priligy Generic Dapoxetine | 60mg | 10 Pills | 47.63€ 45.36€ | |
| Kamagra Soft Tabs | 100mg | 120 + 6 Pills | 311.78€ 296.93€ | |
| Kamagra Gold | 100 mg | 84 + 6 Pills | 264.44€ 251.85€ | |
| Priligy Generic Dapoxetine | 60mg | 90 + 10 Pills | 265.64€ 252.99€ | |
| Priligy Generic Dapoxetine | 60mg | 30 + 6 Pills | 106.65€ 101.57€ | |
| Kamagra Polo | 100mg | 32 Pills | 125.88€ 119.89€ | |
| Priligy Generic Dapoxetine | 60mg | 120 + 10 Pills | 341.26€ 325.01€ | |
| Apcalis SX Oral Jelly | 20mg | 10 Sachets | 58.75€ 55.95€ | |
| Priligy Generic Dapoxetine | 60mg | 20 + 4 Pills | 77.31€ 73.63€ | |
| Kamagra Soft Tabs | 100mg | 60 + 4 Pills | 180.59€ 171.99€ | |
| Cialis Professional | 20mg | 90 + 2 Pills | 241.49€ 229.99€ | |
| Viagra Original | 100mg | 92 + 4 Pills | 362.88€ 345.60€ | |
| Levitra Generic | 60mg | 90 + 6 Pills | 291.82€ 277.92€ | |
| Cialis Generic | 5mg | 20 Pills | 41.99€ 39.99€ |
Menarini New Zealand, New Zealand; A. Menarini Singapore, Vietnam; Berlin-Chemie, Czech Republic; Berlin-Chemie, Germany; Berlin-Chemie, Estonia; Berlin-Chemie, Norway; Berlin-Chemie, Sweden; Janssen-Cilag, Italy; Laboratorios Menarini, Spain; Menarini, Belgium; Menarini, Finland; Menarini, France; Menarini, Georgia; Menarini, Greece; Menarini, Mexico; Menarini, Malaysia; Menarini, Netherlands; Menarini International, Malta; A.Menarini China Holding Co., Ltd., China Priligy 30mgBerlin-Chemie, Austria; Berlin-Chemie, Hungary; Menarini, Switzerland; Menarini, Luxembourg Further information on drug naming conventions: International Nonproprietary Names.
The authors concluded that tadalafil can increase the mean IELT and can be used for treatment of PE in combination with paroxetine. Flushing episodes, as a side effect, were more obvious in group 2 (P = 0.000) [Citation18]. performed a meta-analysis involving 17 trials with 5,739 participants. Seven single medications (paroxetine, fluoxetine, dapoxetine, sertraline, sildenafil, tadalafil and placebo) and five combination therapies were included (tadalafil with sildenafil, tadalafil with fluoxetine, paroxetine with sildenafil, dapoxetine with mirodenafil, and sildenafil with fluoxetine). They concluded that the combination of phosphodiesterase-5 inhibitors and SSRIs were more effective than monotherapy [Citation19].
Elbakary and colleagues evaluated the effectiveness of sildenafil combined with dapoxetine for treating PE. Eighty patients with PE without erectile dysfunction were allocated into 2 groups. The 1st group (40 patients) were given on- demand dapoxetine 30 mg for three months, the 2nd group (40 patients) received an on-demand combination of dapoxetine 30 mg and sildenafil 50 mg for three months. The means of pretreatment and posttreatment IELT among groups were 51.72 ± 12.53 vs 322 ± 24.62 in group 1 and 56.6 ± 10.93 vs 352.5 ± 29.33 in group 2 (P < 0.001). They concluded that combination therapy was associated with better improvement than mono-therapy [Citation20]. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Dapoxetine, a new antidepressant, has been found to be safe and effective for the treatment of premature ejaculation, according to two major clinical trials. Dapoxetin is a short-acting selective serotonin reuptake inhibitor (SSRI).
Comparison between tadalafil plus paroxetine and paroxetine alone in the treatment of premature ejaculation. Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized controlled trials with trial sequential analysis. A prospective randomized study comparing the efficacy and safety of sildenafil with dapoxetine in treatment of premature ejaculation. Which one is the best in premature ejaculation treatment? Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial.
Dalxet is a combination medication used to treat erectile dysfunction (ED) and premature ejaculation (PE) in men. Phosphodiesterase type 5 (PDE5) inhibitor + selective serotonin reuptake inhibitor (SSRI). Available in tablet form, in various pack sizes. Take 1 tablet 1-3 hours before sexual activity, as needed. Store in dapoxetin sildenafil a cool, dry place, away from direct sunlight. It is not uncommon for SSRIs to be used off-label for premature ejaculation. Experts doubt it will be approved by the FDA shortly because SSRIs come with undesirable side-effects after long-term use, such as psychiatric problems, dermatological reactions, increase in body weight, lower sex-drive, nausea, headache, upset stomach and weakness.
Washington, DC: American Psychiatric Association Publishing,; 2022. p. 1. online resource. Shabsigh R, Rowland D.
The diagnostic and Statistical manual of mental disorders, fourth edition, text revision as an appropriate diagnostic for premature ejaculation. doi: 10.1111/j.1743-6109.2007.00557.x Premature ejaculation-emerging concepts and a Novel classification. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities and professional help-seeking. Help-seeking behaviour for sexual problems: the global study of sexual attitudes and behaviors. Efficacy of PDE5Is and SSRIs in men with premature ejaculation: a new systematic review and five meta- analyses. Dr. Jon Pryor, head researcher, University of Minnesota, said that Dapoxetine lengthened ejaculation time and also gave patients more control over ejaculation.
You can read about this in the journal The Lancet. The research team examined the results of two trials, totalling 2,614 men.
Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. doi: 10.1016/j.eururo.2010.02.020 Emerging treatments for premature ejaculation: Focus on dapoxetine. Utility of selective serotonin reuptake inhibitors in premature ejaculation. Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action. Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation?
Development and evaluation of an abridged, 5-item version of the International Index of erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Short-term analysis of the effects of as needed use of sertraline at 5 pm for the treatment of premature ejaculation. doi: 10.1016/S0090-4295(99)00187-9 Gillman N, Gillman M. Premature ejaculation: Aetiology and treatment strategies. Comparison of dapoxetine/tadalafil and paroxetine/tadalafil combination therapies for the treatment of the premature ejaculation: a randomized clinical trial. All the men had from moderate to severe premature ejaculation – on average, the men were ejaculating within one minute of penetration. Half of them were randomly selected to receive Dapoxetine while the other half received a placebo. Both groups had to take their medication from 1 to 3 hours before sexual intercourse.
Participants in group 1 were given tadalafil 5 mg and participants in group 2 were given a combination therapy of dapoxetine 30 mg with tadalafil 5 mg. The means of pretreatment IELT were 1.49 ± 0.51 and 1.47 ± 0.57 minutes in group 1 and 2 respectively. The means of post-treatment IELT were 7.35 ± 4.31 and 9.07 ± 4.2 minutes in groups 1 and 2, respectively, with statistically significant improvements in group 2 (P = 0.045) [Citation21]. Abu El-Hamd M and Abdelhamed A evaluated 150 patients with PE without erectile dysfunction. Five groups of participants, each with 30 patients, were randomly allocated.
For a six-week period, participants in each group received an on-demand placebo, paroxetine (30 mg), dapoxetine (30 mg), sildenafil (50 mg), and a combination of dapoxetine (30 mg) with sildenafil citrate (50 mg). Each participant was told to record his IELT results. The means of pretreatment IELT were 40.33 ± 8.6, 38.66 ± 9.9, 38.86 ± 10.35, 38.66 ± 9.9, and 38.33 ± 10.02 and the means of posttreatment IELT were 41.33 ± 8.3, 173.86 ± 19.8, 171.83 ± 20.7, 175.5 ± 22.4, 266 ± 36.6 in groups 1, 2, 3, 4, 5, respectively. The combination of dapoxetine and sildenafil had the greatest outcomes (p value < 0.001). Headache, nausea and flushing had been the most prevalent side impacts linked with the combination therapy [Citation22]. After three months, the men taking a 30-milligram dose of dapoxetine took an average 2.78 minutes to ejaculate after penetration, those on a 60-milligram dose took 3.32 minutes. The placebo group averaged 1.75 minutes (after three months).